Works matching IS 17427835 AND DT 2024 AND VI 135 AND IP 6

Results: 10

BCPT perspectives on studies involving natural products, traditional Chinese medicine and systems pharmacology.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 6, p. 782, doi. 10.1111/bcpt.14109

By:

Tveden‐Nyborg, Pernille;
Yang, Baoxue;
Simonsen, Ulf;
Lykkesfeldt, Jens

Publication type:

Article

The active ingredient of Evodia rutaecarpa reduces inflammation in knee osteoarthritis rats through blocking calcium influx and NF‐κB pathway.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 6, p. 705, doi. 10.1111/bcpt.14096

By:

Gao, Yan;
Wang, Sixiang;
Gao, Yuehong;
Yang, Li

Publication type:

Article

Improving CYP2C19 phenotyping using stereoselective omeprazole and 5‐hydroxy‐omeprazole metabolic ratios.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 6, p. 755, doi. 10.1111/bcpt.14095

By:

Abouir, Kenza;
Varesio, Emmanuel;
Déglon, Julien;
Samer, Caroline;
Daali, Youssef

Publication type:

Article

Phase I clinical trial evaluating the safety, tolerance, pharmacokinetics and pharmacodynamics of HSK21542 injection in healthy volunteers.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 6, p. 743, doi. 10.1111/bcpt.14094

By:

Shao, Rong;
Wang, Hai‐ying;
Ruan, Zou‐rong;
Jiang, Bo;
Yang, Dan‐dan;
Hu, Yin;
Xu, Yi‐chao;
Yang, Jin‐ting;
Gao, Wei;
Zhao, Wan‐yun;
Yan, Min;
Lou, Honggang

Publication type:

Article

Efficacy of weekly versus daily cholecalciferol for repleting serum vitamin D (25(OH)D) deficiency: A systematic review and meta‐analysis of randomized controlled trials.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 6, p. 685, doi. 10.1111/bcpt.14092

By:

Bortolussi‐Courval, Émilie;
Prosty, Connor;
Lee, Jimin J.;
McCarthy, Lisa M.;
McDonald, Emily G.;
Lee, Todd C.

Publication type:

Article

Cytotoxicity, genotoxicity and mutagenicity of mixed ternary mononuclear Mg complex based on valproic acid with 1,10‐phenanthroline in Saccharomyces cerevisiae and V79 cells.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 6, p. 767, doi. 10.1111/bcpt.14091

By:

Vanini, Julia;
Rodrigues, Gabriel Berbigier;
Juchem, André Luiz Mendes;
Guecheva, Temenouga Nikolova;
Moura, Sidnei;
Dumas, Françoise;
Henriques, João Antonio Pêgas;
de Oliveira, Iuri Marques

Publication type:

Article

An extended substrate spectrum of the proton organic cation antiporter and relation to other cation transporters.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 6, p. 720, doi. 10.1111/bcpt.14090

By:

Ali Khan, Cauzar;
Kirsch, Nicolai;
Brockmöller, Jürgen;
Redeker, Kyra‐Elisa Maria

Publication type:

Article

An overview of major depression disorder: The endocannabinoid system as a potential target for therapy.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 6, p. 669, doi. 10.1111/bcpt.14089

By:

Zarazúa‐Guzmán, Sergio;
Vicente‐Martínez, Jorge Genaro;
Pinos‐Rodríguez, Juan Manuel;
Arevalo‐Villalobos, Jaime Iván

Publication type:

Article

IL‐4 promotes chondrogenesis of bone marrow mesenchymal stem cells and blockade of IL‐4Rα retards the endochondral ossification during rat embryonic bone development.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 6, p. 693, doi. 10.1111/bcpt.14088

By:

Hao, Yimeng;
Meng, Qinghe;
Chang, Leilei;
Qiu, Minglong;
Han, Jianxin;
Wang, Zhiqin;
Li, Changwei;
Ma, Jing;
Zhang, Xuemei

Publication type:

Article

Issue Information.

Published in:: Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, n. 6, p. 667, doi. 10.1111/bcpt.13898
Publication type:: Article